About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

On The Road

Boan Biotech Completes Enrollment of Subjects in Phase I Clinical Trial for Its Neutralizing Antibody Against SARS-CoV-2

News

Luye Pharma Group today announced that all subjects have been enrolled for the phase I clinical trial in China for LY-CovMab, an innovative antibody product developed by Shandong Boan Biotechnology Co. Ltd (Boan Biotech), a subsidiary of the Group. ...

January 19,2021

Luye Pharma’s Innovative Rotigotine Extended-Release Microspheres for Injection Completed Phase I Clinical Trial in Japan

Luye Pharma Group announced today that the phase I clinical trial of the Rotigotine Extended-Release Microspheres for injection (LY03003) for Parkinson’s disease has been completed in Japan. The results show good safety and tolerance ...

January 15,2021

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company